Search
Search Results
##search.searchResults.foundPlural##
-
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1436PDF: 503HTML: 190 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4123PDF: 1173HTML: 2043Fig.1: 223Fig. 2: 117Table 1: 210Table2: 230Table 3: 206 -
-
THE CHALLENGE OF AML IN OLDER PATIENTS
2243PDF: 1001HTML: 2195 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2280PDF: 965HTML: 6820Figure 1: 189 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
838PDF: 548HTML: 4026 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4436PDF: 937HTML: 1341Table1: 191 -
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1671PDF: 1026HTML: 1886Untitled: 207Untitled: 191 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
2424PDF: 1473HTML: 288 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4222PDF: 1992HTML: 1844 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
1594PDF: 892HTML: 7984Untitled: 205 -
SICKLE CELL ANAEMIA AND MALARIA
11648PDF: 7206HTML: 23979Figures Malaria and SCK: 233 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2180PDF: 1028HTML: 4088Cover Letter: 230Figure 1: 242Figure 2: 239Table 1: 212 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3466PDF: 1201HTML: 472 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1362PDF: 1175HTML: 127 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1815PDF: 954HTML: 1147Untitled: 174Untitled: 192Untitled: 175Untitled: 175 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3309PDF: 1483HTML: 5960Fig1-Ag-Pil: 244Ag-Pil Fig.2: 245 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2214PDF: 1744HTML: 559 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3679PDF: 1134HTML: 23361 -
-
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3719PDF: 915HTML: 6775 -
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2339PDF: 1347HTML: 17138Bassan Fig.1: 155Bassan Fig.2: 174Bassan Fig.4: 146Fig.3: 216 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1414PDF: 945HTML: 1668Figure 1: 186 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2209PDF: 1202HTML: 281 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3230PDF: 1132HTML: 1821 -
MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION
2078PDF: 1075HTML: 817Figure 1: 171Figure 2: 189 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4039PDF: 1071HTML: 3720Untitled: 182Cneo. Fig.1: 117Untitled: 111Untitled: 137Untitled: 143 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1335PDF: 610HTML: 3558 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2781PDF: 1038HTML: 208Suppl. Files: 525 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4491PDF: 1661HTML: 4141Tables and Images: 248 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1786PDF: 874HTML: 630







